March 2026 – As the first quarter of 2026 draws to a close, METAvivor, the leading advocate...
Metastatic Breast Cancer Research
Introduction: The Dual Burden of Advocacy and Personal Survival For Dr. Kelly Shanahan, the boundary between professional...
Introduction: The Advocacy Imperative In the ongoing evolution of the COVID-19 pandemic, the landscape of public health...
The landscape of oncology is witnessing a transformative shift as a new cohort of distinguished researchers receives...
Executive Summary: A Month of Legislative Mobilization February has proven to be a pivotal month for METAvivor,...
By Editorial Staff In the high-stakes world of medical research, the intersection of patient advocacy and scientific...
By the METAvivor Advocacy Team As the legislative calendar accelerates following the conclusion of the April congressional...
Introduction: The Unpredictable Nature of MBC For Kelly Shanahan, M.D., the President of METAvivor, life with metastatic...
By The METAvivor Advocacy Team As the calendar turned to January, the advocacy landscape in Washington, D.C.,...
Introduction As the landscape of oncology continues to shift toward precision medicine and patient-centric research, organizations like...
